Normal horse and guinea pig sera contain the glycoprotein inhibitor a2-macroglobulin, which inhibits the infectivity and hemagglutinating activity of influenza A viruses of the H2 and H3 subtypes. In the current study, the presence of inhibitors of influenza A virus in pig and rabbit sera was investigated. Variants of influenza virus type A/Los Angeles/2/87(H3N2) that were resistant to horse, pig, or rabbit serum were isolated. Analysis of the variant viruses with anti-hemagglutinin (HA) monoclonal antibodies revealed that antigenic changes occurred with the development of serum inhibitor resistance. Characterization of the inhibitors in pig and rabbit sera by using periodate and receptor-destroying enzyme demonstrated that carbohydrate is an important constituent of the active portion of both inhibitor molecules and that sialic acid is involved in the interaction of the inhibitors with influenza virus HA. Nucleotide sequence analysis of the HA molecule revealed that the serum-resistant variants each acquired a different set of amino acid alterations. The multiply resistant variants maintained the original amino acid changes and acquired additional changes. Sequence modifications in the HA involved the conserved amino acids within the receptor binding site (RBS) at position 137 and the second-shell RBS residues at positions 155 and 186. Amino acid changes also occurred within antigenic site A (position 145) and directly behind the receptor binding pocket (position 220). Amino acid alterations resulted in the acquisition of a potential glycosylation site at position 128 and the loss of potential glycosylation sites at positions 246 and 248. The localization of the amino acid changes in HAl to the region of the RBS supports the concept of serum inhibitors as receptor analogs. The unique set of mutations acquired by the serum inhibitor-resistant variants strongly suggests that horse, pig, and rabbit sera each contain distinct glycoprotein inhibitors of influenza A virus.
Hemagglutinin (HA), the major surface glycoprotein of influenza virus, functions in binding to host cell sialyloligosaccharide receptors. This binding is crucial for the initiation of an influenza virus infection. The HA molecule is composed of a stalk region that includes the HA1/HA2 cleavage site and a globular domain containing the receptor binding site (RBS) (35) . The RBS is located at the distal tip of the HA molecule in a surface depression (or pocket) which is lined by a series of conserved amino acid residues and is surrounded by variable antigenic sites. The sialic acid moieties of host cell receptors must become oriented in the RBS in a defined fashion and interact with specific amino acids within the pocket (34) . Receptor binding specificity is determined by the ability of the HA molecule to correctly associate with different cell surface sialyloligosaccharides. Comparisons of influenza viruses from various animal species have elucidated differences in their abilities to recognize particular terminal sialic acid sequences (6, 22, 26) . The variation in receptor specificities among human, avian, and equine influenza A viruses suggests that the presence of different receptors in their different host animals and the ability of HA to bind to these receptors are factors associated with viral host range and tissue tropism (10, 20, 25) .
Naturally occuring inhibitors of HA activity of influenza viruses have been demonstrated in different animal sera (including human sera) and in fluid secretions such as ovomucin, bovine submaxillary mucin, and pleural fluid (for reviews, see references 2, 13, and 19) . First 1947 by Francis (11) , the alpha class of inhibitors were found to be heat-stable sialylated glycoproteins that inhibit hemagglutination but do not neutralize viral infectivity. Beta inhibitors, on the other hand, are heat-labile components of normal sera which are thought to be proteins and which possess virus-neutralizing activity (3, 12) . The gamma class of inhibitors are heat-stable sialylated glycoproteins, but unlike alpha inhibitors, they can neutralize viral infectivity (5, 8) . Inhibitors in the alpha and gamma classes are known to function as receptor analogs by competing with host cell receptors for binding to HA.
The gamma-type inhibitor present in horse and guinea pig sera, a2-macroglobulin, is the best-characterized nonspecific inhibitor (14, 23, 28) . It is active against human influenza A viruses of the H2 and H3 subtypes. Studies with variant H3 viruses, which are resistant to horse serum, have provided insight into the nature of the binding of the receptor or the inhibitor within the RBS of HA. Human influenza viruses of the H3 subtype recognize N-acetylneuraminic acid-a2,6-galactose (NeuAc2,6Gal) linkages of host cell sialic acids and are sensitive to horse serum inhibitor, whereas avian and equine influenza viruses recognize NeuAc2,3Gal linkages and are resistant to horse serum inhibitor (26) . A single amino acid change of leucine to glutamine at position 226 of HAl, which lies within the receptor binding pocket, confers horse serum resistance to NeuAc2,6Gal-specific viruses and changes the specificity of the virus to NeuAc2,3Gal (26) . Horse and guinea pig a2-macroglobulin contains the sialic acid 4-O-acetyl-N-acetylneuraminic acid, which resists hydrolysis by viral neuraminidase (14) . The presence of this uncommon sialic acid combined with a spatial arrangement of sialic acid groups that allows optimal interaction with HA is thought to be the basis for the high-potency inhibition found with equine and guinea pig sera (14, 23 (Table  2) , hemagglutination of these variants was inhibited to some extent by the sera, suggesting the presence of nonneutralizing inhibitors (Table 1) . To establish the difference between inhibitors in horse and pig sera, the neutralizing activity of pig serum against A/LA HS was examined. A/LA HS was sensitive to neutralization by pig serum, with a greater than 1,000-fold reduction in the EID50 ( Table 2 ). The fact that A/LA HS was sensitive to neutralization by pig serum supported previous indications that the inhibitors in the two sera were different. A/LA HSPS BB was the serum-resistant variant isolated from a Viruses were isolated at limiting dilution in 11-day-old embryonated chicken eggs after incubation of the virus with an equal volume of undiluted animal serum at room temperature for 1 h. b Sera were treated with 0.1 M Kb04 for 15 min at 20°C. The K04 was inactivated with 1% glycerol saline (21) .
c Sera were treated with V. cholerae RDE for 12 h. The RDE was inactivated with 2.5% sodium citrate (21) .
A/LA HS after exposure to pig serum. By the HI assay, A/LA HSPS BB was resistant to both horse and pig sera and had reduced sensitivity to rabbit serum. A/LA HSPS was subsequently isolated by exposure of the parent virus to horse and pig sera simultaneously. This variant had to overcome the inhibitory effects of two sera at the same time in order to grow in eggs. By the HI assay, A/LA HSPS was resistant to both homologous sera and had reduced sensitivity to rabbit serum. This data clearly separated the inhibitors in horse serum from those in pig serum.
To distinguish the inhibitors in pig and rabbit sera, the neutralizing activity of rabbit serum against A/LA HSPS was examined and the variant A/LA HSPSRS was isolated. Growth of A/LA HSPS was neutralized by the presence of rabbit serum with a 100,00-fold reduction in EID50. The sensitivity of A/LA HSPS to neutralization by rabbit serum established that the inhibitors in rabbit serum were not identical to those in horse and pig sera. A/LA HSPSRS showed marked resistance to all three sera in the HI test.
The patterns of sensitivity of the viruses to neutralization and HI by horse, pig, and rabbit sera verify the presence of heat-stable, neutralizing inhibitors in all three sera and provide strong evidence that the inhibitors in each type of serum are different.
Preliminary characterization of the inhibitors in pig and rabbit sera. To understand the chemical nature of the inhibitors in pig and rabbit sera and to compare them with the horse serum inhibitors, the sera were treated with either periodate or RDE and then tested for their neutralizing activity against A/LA/2/87. Periodate, which oxidizes cishydroxyl groups on carbohydrates, removed all neutralizing activity found in horse, pig, and rabbit sera (data not shown). RDE treatment of serum cleaves N-acetylneuraminic acid residues from sialyloligosaccharides. As with periodate treatment, RDE treatment of the three sera essentially removed all virus-neutralizing activity (data not shown). The sera were then analyzed by the HI assay for inhibitory activity (Table 3) . Periodate removed all inhibitory activity found in horse and pig sera, while residual inhibitory activity was found in periodate-treated rabbit serum. RDE treatment of pig serum destroyed all inhibitory activity, whereas RDEtreated horse and rabbit sera retained some inhibitory activity. The results with periodate and RDE suggest that carbohydrate and sialic acid are important components of the inhibitor molecules in all three sera.
Antigenic variation associated with the development of serum inhibitor resistance. Influenza viruses which differ in their receptor binding specificities and in their sensitivities to horse serum inhibitor are also known to differ in the antigenicity of their HA molecules (9) . To assess whether the development of resistance to inhibitors in pig and rabbit sera is associated with antigenic changes in the HA molecule, the different variants were tested in HI reactions using a panel of monoclonal antibodies (Table 4) Nucleotide and deduced amino acid sequences of parent and variant viruses. To examine the molecular basis for the resistance to the inhibitors in different sera and the altered reactivity to monoclonal antibodies, we deduced the amino acid sequence of HAl from the nucleotide sequences of parent and variant viruses ( Table 5 ). The nucleotide sequences of the HAs of all the viruses were derived from genomic RNA, and the ambiguities were verified by sequence analysis of cloned cDNA. In order to facilitate comparison with other H3 strains, and for localization of amino acid residues in the three-dimensional structure, we used the amino acid numbering system of A/Aichi/2/ 68(H3N2) (32) . All of the amino acid sequence changes in the serum inhibitor-resistant variants occurred in the globular domain of HAl either within or around the RBS (Fig. 1) . The Three amino acid changes in the variants occured either directly within the RBS (137) or at residues corresponding to the second shell of RBS residues (155 and 186). The other amino acid changes occured in a loop of amino acids adjacent to the RBS (145), behind the RBS (220), and at potential glycosylation sites (128, 246, and 248) (Fig. 1) . The location of the amino acid changes in the variants in or near the RBS strongly supports the concept of the serum inhibitors as substances binding to HA via the RBS, thereby inhibiting the binding of the virus to a host cell receptor. These findings also indicate that different mutations in HA are required to overcome the inhibitory effect of the glycoprotein inhibitors in horse, pig, and rabbit sera, strongly suggesting that the inhibitors in these animal sera are structurally distinct.
DISCUSSION
In the current study, we have demonstrated that nonspecific glycoprotein inhibitors of influenza A virus exist not only in horse serum but also in pig and rabbit sera. Inhibitors of influenza virus have been observed previously in rabbit serum; however, the serum was not assessed for neutralizing activity (31) . To our knowledge there are no published data dealing with the nonspecific inhibitors in swine sera. Our data establish the presence of glycoprotein inhibitors in pig and rabbit sera which inhibit HA activity, neutralize virus infectivity, and are thermostable. The inhibitors in the animal sera could be distinguished by differential virus neutralization. The nucleotide sequences of the HAs of the serum-resistant variants demonstrated that horse, pig, and rabbit sera each generate unique modifications in HA. Thus, these data affirmed at the molecular level that different mutations in the HA molecule are required to overcome the inhibitory activity of each of the sera. These results support the hypothesis that there are distinct glycoprotein inhibitors present in the sera of different animal species, each of which interacts with the HA of influenza A virus in a specific manner.
Characterization of the serum inhibitors by chemical modification with periodate and RDE provided evidence that carbohydrate and sialic acid are important elements of the active portions of the inhibitors in pig and rabbit sera. The importance of these two constituents has already been established for the glycoprotein inhibitor a-2-macroglobulin in horse serum (14, 23) . Isolation, purification, and detailed chemical analysis of the pig and rabbit serum inhibitors are in progress as a means of thoroughly understanding the nature of the inhibitor molecules and how they interact with HA as receptor analogs.
Molecular analysis of the HAs of the variants revealed that distinct amino acid changes were required in each variant to overcome the inhibitory effect of horse, pig, or rabbit serum (Fig. 1) . A/LA HS acquired an amino acid alteration at position 145, which is part of a loop of amino acids lying immediately adjacent to the RBS and constituting part of antigenic site A (35) . A change in this region of the HA molecule could conceivably alter the orientation of sialic acid on the inhibitor within the RBS. A/LA HS also acquired a change at position 155, and A/LA PS acquired a change at position 186. These amino acids are within the receptor binding pocket but do not interact directly with the sialic acid of the receptor via hydrogen bonds or van der Waals contacts (34) . Instead, they can be considered part of a second shell of residues which stabilize the RBS and interact secondarily with sialic acid through other residues in the binding pocket. On the basis of the proposed interactions of sialic acid with RBS residues set forth by Weis et al. (34) , amino acid residue 155 interacts with amino acid 194, which binds to N-acetylneuraminic acid via the hydroxyl group of C7. Amino acid residue 186 interacts secondarily with the hydroxyl group of C9 via amino acid residues 190 and 228. This suggests that the inhibitors in horse and pig sera may be modified at these areas of the sialic acid moieties (e.g., by acetylation to 7-O-acetyl or 9-O-acetyl neuraminic acid) and thereby induce the alterations at positions 155 and 186. A/LA RS acquired an amino acid alteration at position 220, which lies posterior to the RBS. This amino acid is near amino acids 224 through 228, forming one wall of the pocket. The change from arginine to glycine at this position results in a considerable change in the size and charge of the amino acid residue, which may change the conformation of the HA in such a way as to subsequently affect receptor binding with residues 224 through 228. A/LA HS and A/LA RS both had alterations at amino acid residues which could affect the glycosylation of the HA molecule. These amino acid residues (128 and 246) are located at points distant from the RBS. However, the loss or acquisition of glycosylation sites could indirectly influence binding of the inhibitor by interfering with the proper orientation of the inhibitor in the pocket or by altering the access of the inhibitor to certain critical residues within the pocket.
A In the present study, we did not attempt to obtain multiple isolates resistant to the same serum, except with horse serum. The nucleotide sequence of a second (independently isolated) horse serum-resistant variant was found to be identical to that of the first (data not shown). However, it is possible that resistant strains containing different amino acid substitutions could be selected by the same serum.
Antigenic comparison using anti-HA monoclonal antibodies revealed changes in the HAs of the serum-resistant variants. The development of resistance to both horse and pig sera (A/LA HSPS and A/LA HSPS BB) or to all three sera (A/LA HSPSRS) resulted in a greater degree of antigenic variation than one would expect if the alterations were simply additive. This suggests that additional changes in the HA may lead to alterations in the conformation of the HA at antigenic sites, around the RBS, or between HA subunits, thus decreasing the ability of antibodies to bind.
Host cell selection of antigenic variants has been shown to occur with influenza A and B viruses (10, 16, 24, 30 (16, 17, 18, 33) . Many of these amino acid residues are also altered in our serum-resistant variants, supporting the concept that these amino acid residues are important for the interaction of HA with host cell receptor molecules.
In the case of the early human H3N2 virus X-31, horse serum resistance has been shown previously to result in a single amino acid change at position 226, which is part of a group of conserved amino acids forming one lateral wall of the RBS of the HA molecule (27) . However, the horse serum-resistant variant derived from A/LA/2/87 did not have an amino acid change at position 226. It is not known why the development of horse serum resistance with A/LA/2/87 did not result in a change at amino acid 226. It is possible that variations in HA as a result of genetic drift have occurred over time such that an amino acid change at position 226 no longer confers resistance to horse serum. Within the same context, the neutralization of A/LA/2/87 observed with the animal sera in our studies may be due to inhibitors previously characterized as nonneutralizing with earlier H3 viruses. The fact that RDE-treated horse serum did not inhibit hemagglutination of A/LA/2/87, in contrast to what has been shown with other H3 viruses, provides support for variations in the H3 hemagglutinin (23) .
The presence of nonneutralizing inhibitors in normal pig and rabbit sera could account for the residual activity observed with A/LA PS and A/LA RS, respectively, in the HI assay ( 
